{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:28:09Z","timestamp":1768829289710,"version":"3.49.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Dutch Arthritis Society"},{"name":"Dutch Arthritis Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The crosstalk between the immune and nervous system in the regulation of OA pain is increasingly becoming evident. GM-CSF signals in both systems and might be a new treatment target to control OA pain. Anti GM-CSF treatment has analgesic effects in OA without affecting synovitis scores, suggesting that treatment effects are not caused by local anti-inflammatory effects. We aimed to evaluate whether expression of GM-CSF and its receptor GM-CSFr\u03b1 in synovial tissue is linked to synovial inflammation and\/or knee pain in knee OA patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cartilage and synovial tissue of knee OA patients (n\u2009=\u200920) was collected during total knee replacement. Cartilage damage was evaluated by histology and ex vivo matrix proteoglycan turnover. Synovial inflammation was evaluated by histology and ex vivo synovial production of TNF-\u03b1, (PGE2) and nitric oxide (NO). Numbers of synovial tissue cells expressing GM-CSF or GM-CSFr\u03b1 were determined by immunohistochemistry. Pain was evaluated using WOMAC questionnaire and visual analogue scale (VAS) knee pain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Collected cartilage and synovial tissue had a typical OA phenotype with enhanced cartilage damage and synovial inflammation. GM-CSF and GM-CSFr\u03b1 expressing cells in the synovial sublining correlated negatively with knee pain. Cartilage damage and synovial inflammation did not correlate with knee pain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Unanticipated, the negative correlation between synovial tissue cells expressing GM-CSF(r) and OA knee pain suggests that local presence of these molecules does not promote pain, and that the role of GM-CSFr in OA pain is unrelated to local inflammation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>ToetsingOnline.nl NL18274.101.07.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa199","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T19:12:51Z","timestamp":1585854771000},"page":"3452-3457","source":"Crossref","is-referenced-by-count":7,"title":["Expression of granulocyte macrophage-colony stimulating factor and its receptor in the synovium of osteoarthritis patients is negatively correlated with pain"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3540-4892","authenticated-orcid":false,"given":"Eefje M","family":"van Helvoort","sequence":"first","affiliation":[{"name":"Department of Rheumatology & Clinical Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Eijkelkamp","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris P J G","family":"Lafeber","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Clinical Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon C","family":"Mastbergen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Clinical Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2020102707112587300_keaa199-B1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","article-title":"Therapeutic options for targeting inflammatory osteoarthritis pain","volume":"15","author":"Conaghan","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2020102707112587300_keaa199-B2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12032-013-0774-6","article-title":"Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor","volume":"31","author":"Francisco-Cruz","year":"2014","journal-title":"Med Oncol"},{"key":"2020102707112587300_keaa199-B3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2020102707112587300_keaa199-B4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.it.2017.12.003","article-title":"Immune cytokines and their receptors in inflammatory pain","volume":"39","author":"Cook","year":"2018","journal-title":"Trends Immunol"},{"key":"2020102707112587300_keaa199-B5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.52.12.870","article-title":"Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis","volume":"52","author":"Farahat","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2020102707112587300_keaa199-B6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2016-210624","article-title":"A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis","volume":"76","author":"Burmester","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020102707112587300_keaa199-B7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"Behrens","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020102707112587300_keaa199-B8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-019-1879-x","article-title":"Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial","volume":"21","author":"Taylor","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2020102707112587300_keaa199-B9","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar4037","article-title":"Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development","volume":"14","author":"Cook","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2020102707112587300_keaa199-B10","first-page":"1494","article-title":"A phase IIa study of anti-GM-CSF antibody GSK3196165 in subjects with inflammatory hand osteoarthritis. Abstract 1365","volume":"70(Suppl. 9","author":"Schett","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020102707112587300_keaa199-B11","first-page":"1006","article-title":"Lack of a clear disease modifying activity of celecoxib treatment of end-stage knee osteoarthritis: a randomized observer blinded clinical trial","volume":"1","author":"Van Helvoort","year":"2017","journal-title":"JSM Bone Joint Dis"},{"key":"2020102707112587300_keaa199-B12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.joca.2004.07.009","article-title":"The canine \u2018groove\u2019 model of osteoarthritis is more than simply the expression of surgically applied damage","volume":"14","author":"Mastbergen","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"2020102707112587300_keaa199-B13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.joca.2013.06.018","article-title":"The innervation of synovium of human osteoarthritic joints in comparison with normal rat and sheep synovium","volume":"21","author":"Eitner","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"2020102707112587300_keaa199-B14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.joca.2018.06.006","article-title":"Synovial nerve fiber density decreases with naturally-occurring osteoarthritis in horses","volume":"26","author":"Pujol","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"2020102707112587300_keaa199-B15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/ard.2004.025270","article-title":"Synovial tissue inflammation in early and late osteoarthritis","volume":"64","author":"Benito","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2020102707112587300_keaa199-B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2474-9-116","article-title":"The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature","volume":"9","author":"Bedson","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"2020102707112587300_keaa199-B17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/j.pain.0000000000001130","article-title":"Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain","volume":"159","author":"Nicol","year":"2018","journal-title":"Pain"},{"key":"2020102707112587300_keaa199-B18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.04.003","article-title":"Sensitization in patients with painful knee osteoarthritis","volume":"149","author":"Arendt-Nielsen","year":"2010","journal-title":"Pain"},{"key":"2020102707112587300_keaa199-B19","doi-asserted-by":"crossref","first-page":"iv43","DOI":"10.1093\/rheumatology\/kex419","article-title":"Osteoarthritis: the genesis of pain","volume":"57","author":"Fu","year":"2018","journal-title":"Rheumatology"},{"key":"2020102707112587300_keaa199-B20","first-page":"797","article-title":"EULAR recommendations for the health professional\u2019s approach to pain management in inflammatory arthritis and osteoarthritis","volume":"77","author":"Geenen","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3452\/34038259\/keaa199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3452\/34038259\/keaa199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:59:48Z","timestamp":1603799988000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/11\/3452\/5829671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,5,4]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa199","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,5,4]]}}}